Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality
worldwide. Despite advances in treatment, the prognosis remains poor, highlighting the …

Non-small cell lung cancer is a heterogeneous disease and molecular characterisation
plays an important role in its clinical management. Next-generation sequencing-based …

Liquid biopsies based on extracellular vesicles (EVs) represent a promising tool for
treatment monitoring of tumors, including non-small-cell lung cancers (NSCLC). In this study …

Introduction The frequency of actionable mutations varies between races, and
Hispanic/Latino (H/L) people are a population with different proportions of ancestry. Our …

Tyrosine kinase inhibitors are a clinically standard treatment option for non‑small cell lung
cancers (NSCLCs), the leading cause of cancer‑related deaths in the US. These targeted …

Simple Summary Lung cancer is the leading cause of cancer related deaths and non-small
cell lung cancer (NSCLC) is its most relevant subtype. Here, we present data on p53 co …

There continues to be a need for cancer-specific ligands that can deliver a wide variety of
therapeutic cargos. Ligands demonstrating both tumor-specificity and the ability to mediate …

Simple Summary Identification of novel therapeutic strategies for the treatment of non-small
cell lung cancer (NSCLC) remains an urgent need in the area of lung cancer research …

Background/Aim: Gliomas are primary malignancies of the central nervous system (CNS).
High-grade gliomas are associated with poor prognosis and modest survival rates despite …

Lung cancer represents a significant global health concern and stands as the leading cause
of cancer-related mortality worldwide. The identification of specific genomic alterations such …